JP2015504897A5 - - Google Patents

Download PDF

Info

Publication number
JP2015504897A5
JP2015504897A5 JP2014552287A JP2014552287A JP2015504897A5 JP 2015504897 A5 JP2015504897 A5 JP 2015504897A5 JP 2014552287 A JP2014552287 A JP 2014552287A JP 2014552287 A JP2014552287 A JP 2014552287A JP 2015504897 A5 JP2015504897 A5 JP 2015504897A5
Authority
JP
Japan
Prior art keywords
virus
hpv
protein
antigen
particle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014552287A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015504897A (ja
JP6185932B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/020960 external-priority patent/WO2013106525A1/en
Publication of JP2015504897A publication Critical patent/JP2015504897A/ja
Publication of JP2015504897A5 publication Critical patent/JP2015504897A5/ja
Application granted granted Critical
Publication of JP6185932B2 publication Critical patent/JP6185932B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014552287A 2012-01-12 2013-01-10 免疫原性のｈｐｖのｌ２を含むｖｌｐ並びに関連する組成物及び方法 Expired - Fee Related JP6185932B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261585839P 2012-01-12 2012-01-12
US61/585,839 2012-01-12
PCT/US2013/020960 WO2013106525A1 (en) 2012-01-12 2013-01-10 Immunogenic hpv l2-containing vlps and related compositions and methods

Publications (3)

Publication Number Publication Date
JP2015504897A JP2015504897A (ja) 2015-02-16
JP2015504897A5 true JP2015504897A5 (enExample) 2016-03-03
JP6185932B2 JP6185932B2 (ja) 2017-08-23

Family

ID=48781889

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014552287A Expired - Fee Related JP6185932B2 (ja) 2012-01-12 2013-01-10 免疫原性のｈｐｖのｌ２を含むｖｌｐ並びに関連する組成物及び方法

Country Status (8)

Country Link
EP (1) EP2802349B1 (enExample)
JP (1) JP6185932B2 (enExample)
CN (1) CN104159606A (enExample)
AU (1) AU2013207962B2 (enExample)
BR (1) BR112014017242A8 (enExample)
CA (1) CA2861021A1 (enExample)
HK (1) HK1203837A1 (enExample)
WO (1) WO2013106525A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9549976B1 (en) 2012-11-16 2017-01-24 Stc.Unm Affinity selection of Nipah and Hendra virus-related vaccine candidates from a complex random peptide library displayed on bacteriophage virus-like particles
US10258698B2 (en) 2013-03-14 2019-04-16 Modernatx, Inc. Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
WO2015034925A1 (en) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Circular polynucleotides
CA2923029A1 (en) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Chimeric polynucleotides
US9943580B2 (en) 2013-09-12 2018-04-17 Stc.Unm Malaria vaccine
KR20160067219A (ko) 2013-10-03 2016-06-13 모더나 세라퓨틱스, 인코포레이티드 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
WO2017136400A1 (en) * 2016-02-02 2017-08-10 Stc. Unm Vlp-based vaccines for targeting staphylococcus aureus secreted virulence factors
JP6916209B2 (ja) * 2016-05-13 2021-08-11 フラッシュ セラピューティクス 特に免疫応答に関与する細胞への、ｒｎａの転移のためのウイルス粒子
AU2018270111B2 (en) 2017-05-18 2022-07-14 Modernatx, Inc. Polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and uses thereof
CA3076631A1 (en) 2017-09-29 2019-04-04 Deutsches Krebsforschungszentrum Cutaneous papilloma virus vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113809D0 (en) * 1991-06-26 1991-08-14 Cancer Res Campaign Tech Papillomavirus l2 protein
GB9420146D0 (en) * 1994-10-06 1994-11-23 Cancer Res Campaign Tech Papillomavirus vaccine
US7264810B2 (en) * 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
US20090028886A1 (en) * 2004-08-04 2009-01-29 Cytos Biotechnology Ag Carrier conjugates of gnrh-peptides
WO2011100234A2 (en) * 2010-02-09 2011-08-18 Stc.Unm Immunogenic hpv l2-containing vlps and related compositions, constructs, and therapeutic methods

Similar Documents

Publication Publication Date Title
Jain et al. Formulation and stabilization of recombinant protein based virus-like particle vaccines
JP2012010713A5 (enExample)
TR201908199T4 (tr) HPV'ye karşı aşılar.
JP2014530010A5 (enExample)
JP2013216685A5 (enExample)
EA201190327A1 (ru) Новые конструкции белка вируса папилломы человека (hpv) и их применение в предупреждении заболевания, вызываемого hpv
CN106659777A8 (zh) 免疫原性组合产品
SG131116A1 (en) Functional influenza virus-like particles (vlps)
JP2014502156A5 (enExample)
MX2015011484A (es) Vacunas mejoradas para el virus de papiloma humano y metodos para utilizarlas.
EP2589604A4 (en) SHORTEN L1 PROTEIN OF THE TYPE 52 HUMAN PAPILLOMA VIRUS
JP2013523686A5 (enExample)
NZ595710A (en) Recombinant virus-like particles encoded by multi-gene vector
JP2015524422A5 (enExample)
JP2006512413A5 (enExample)
MY197457A (en) Chimeric papillomavirus l1 protein
BR112014017242A8 (pt) vlps contendo hpv l2 imunogênico e composições e métodos relacionados
JP2010506926A5 (enExample)
JP2013541528A5 (enExample)
JOP20220187A1 (ar) لقاح فيروس الورم الحليمي البشري (hpv)
JP2019502404A5 (enExample)
MX2019007924A (es) Vacunas contra la influenza.
WO2018066999A3 (en) Chimeric enterovirus virus-like particles
MY207280A (en) Polyvalent immunogenicity composition for human papillomavirus
Sharma et al. A synthetic chimeric peptide harboring human papillomavirus 16 cytotoxic T lymphocyte epitopes shows therapeutic potential in a murine model of cervical cancer